//Safety Assessment for the Investigational New Drug (IND) Application

Safety Assessment for the Investigational New Drug (IND) Application

March 21, 2017

March21Sue McPherson, Executive Director of Toxicology
WuXi AppTec

The success of an Investigational New Drug (IND) applications is one of the key milestones of the drug development process. Sue McPherson from WuXi AppTec Lab Testing Division will be talking about the Drug Safety Assessment, a critical piece in the IND package. She will be sharing information on basic requirements, project implementation, timelines, as well as overall strategies for a successful IND application. She will also invite you to an in-depth look into the WIND program, an integrated service platform for your IND project currently offered by WuXi AppTec.

2018-09-23T09:17:43+00:00March 21st, 2017|Events 2017|